Published online before print May 17, 2002, 10.1148/radiol.2241011223
MR Cholangiography in Symptomatic Gallstones: Diagnostic Accuracy according to Clinical Risk Group1
Joo Hee Kim, MD,
Myeong-Jin Kim, MD,
Sung Il Park, MD,
Jae-Joon Chung, MD,
Si Young Song, MD,
Kyung Sik Kim, MD,
Hyung Sik Yoo, MD,
Jong Tae Lee, MD and
Ki Whang Kim, MD
1 From the Department of Diagnostic Radiology (J.H.K., M.J.K., S.I.P., J.J.C., H.S.Y., J.T.L., K.W.K.), BK21 Project for Medical Science (M.J.K.), Division of Gastroenterology, Department of Internal Medicine (S.Y.S.), and Department of Surgery (K.S.K.), Yonsei University College of Medicine, Seodaemun-ku Shinchon-dong 134, Seoul 120-752, Korea. Received July 19, 2001; revision requested September 11; revision received October 25; accepted December 10. Supported by Yonsei University Research Fund of 2001. Address correspondence to M.J.K. (e-mail: kimnex@yumc.yonsei.ac.kr).

View larger version (114K):
[in a new window]
|
Figure 1. Coronal thick-section ( /1,079 [effective]; 50-mm thickness) MR cholangiographic image obtained in a 57-year-old man with a high risk of CBD stones and an elevated bilirubin concentration (>1.5 mg/dL [>25.6 µmol/L]). Patient had a true-positive diagnosis of a CBD stone. Image shows a single stone (arrow) in the distal lumen of the CBD.
|
|
Copyright © 2002 by the Radiological Society of North America.